Active — Not RecruitingNot Applicable

teleABLE to Reduce Post-Stroke Sedentary Behavior

United States90 participantsStarted 2024-04-04

Plain-language summary

The goal of this clinical trial to test whether a remotely delivered behavioral activation-based intervention called "teleABLE" works better than a health education intervention for (1) reducing sitting time and (2) improving health-related quality among adults who were diagnosed with stroke within the past 12 months. Participants in this study will: * Complete questionnaires at Weeks 1, 8, and 24 * Wear an activPAL monitor at Weeks 1, 8, and 24 * Participate in the teleABLE intervention (12 sessions) or the health education intervention (6 sessions) * Complete an interview at Week 24

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: 18 years or older * Diagnosis: Stroke diagnosis ≤12 months prior to study enrollment * ≥6 hours of sedentary behavior on a typical weekday (Sedentary Behavior Questionnaire) * Able to walk 150 feet or more without physical assistance from another person, with or without assistive device (assessed by Functional Independence Measure, mobility score ≥5) * Able to access an electronic device (smartphone, tablet, or computer) that is compatible with a videoconferencing application * Able to identify a support person with whom they have a face-to-face interaction at least one time per week. * Able and willing to participate fully in the study and provide informed consent Exclusion Criteria: * Currently receiving care in an inpatient rehabilitation, transitional care unit, or skilled nursing facility * Severe cognitive or communication impairments (inability to respond accurately to complete study telephone screening or complete informed consent) * Comorbid neurodegenerative disorder (e.g. Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma) * Comorbid cancer, currently undergoing chemotherapy or radiation treatment * Comorbid major depressive disorder (Patient Health Questionnaire-2, score ≥2) * Received inpatient treatment or hospitalized for psychiatric condition and/or alcohol or substance abuse within the past 12 months * Diagnosis of a terminal…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Between-group difference in change scores on health-related quality of life

Timeframe: Week 0 to Week 8

Between-group difference in change in sedentary behavior

Timeframe: Week 0 to Week 8

Trial details

NCT IDNCT06312709

SponsorUniversity of Minnesota

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-28

View on ClinicalTrials.gov More Stroke trials